The 10th Federation of African Immunological Societies (FAIS) Congress, held in Tunisia in November 2017, marked a significant scientific milestone. It enabled scientists from across the continent to promote immunology research and to showcase major achievements made by immunologists throughout Africa. This issue of the Journal of Leukocyte Biology (JLB) features manuscripts from the FAIS Congress. As noted in these papers, research in infectious diseases remains the focus of the African immunology community; however, increasingly noncommunicable diseases-such as autoimmunity, allergy, primary immunodeficiency, cancer and transplantation immunology-are also an emerging priority. This overview gives a brief history of the FAIS meeting, which also commemorated the 25th anniversary of the FAIS. It describes the current activities of the organization, as well as its history and the future opportunities for this Federa- Although infectious diseases remain a serious public health concern and significant area of study, interest in the study of noncommunicable immune-related diseases is increasing. In line with this evolution, the JLB cluster of papers also places a particular focus on
RESEARCH PRESENTED DURING THE 10TH FEDERATION OF AFRICAN IMMUNOLOGY SOCIETIES CONGRESS
The Congress, held on December [3] [4] [5] [6] [7] 2017 Although infectious diseases remain a serious public health concern and significant area of study, interest in the study of noncommunicable immune-related diseases is increasing. In line with this evolution, the JLB cluster of papers also places a particular focus on autoimmunity. For example, Hatem Masmoudi and colleagues 6 
FAIS HISTORICAL BACKGROUND
The 10th FAIS Congress in December 2017 coincided with the 25th anniversary of the founding of the society in 1992. The establishment of FAIS was driven by the urgent need to develop African expertise to address the emergence of HIV and the AIDS epidemic, which exposed several shortcomings in the biomedical infrastructure in Africa, including those in institutional organization, personnel, and funding. Scientists from outside Africa, including Peter Piot and colleagues, 11, 12 Serwadda and colleagues, 13 and van der Pierre and colleagues, 14 
CONCLUSION
The African continent, which has the lowest income per capita juxtaposed with the highest burden of several overlapping diseases, including malaria, tuberculosis, HIV, and neglected tropical diseases, faces many challenges. The emergence and reemergence of often devastating diseases such as that due to Ebola virus exacerbates the vicious circle of poverty and disease. The availability of human resources is essential to meet the challenge, to develop robust surveillance and monitoring systems to predict and control diseases, and to advance vaccine development. The FAIS has provided a framework to nurture human resource development, robust institutions, and sustainable funding. There is a need to establish, grow, and strengthen national research capacity and to support sustainable funding for resident African scientists to monitor diseases and provide science-based data to better inform policy. During its brief 25-year history, the FAIS has made significant advances in strengthening of African research capacity. The quality of research and the numbers of young researches have increased. The African research landscape has been transformed and it is hoped that support from all partners will be increased and sustained.
Tracing the rise of FAIS
The FAIS was primarily developed as a way of increasing the pool 
